Dream Finders Homes, Inc. revenue by segment DFH

Dream Finders Homes, Inc. splits its revenue into 2 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Home Building at $942.3 million, 95% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Revenue
4,160
996
1,063
888
1,213
970
1,151
990
1,560
Home Building
3,945
-12.7%
share 94.8%
942
+2.8%
share 94.6%
1,007
-8.4%
share 94.7%
837
-13.8%
share 94.2%
1,159
-24.5%
share 95.6%
917
share 94.5%
1,100
share 95.6%
970
share 98.0%
1,534
share 98.4%
Financial Service
215
+43.7%
share 5.2%
54
+1.1%
share 5.4%
56
+10.5%
share 5.3%
51
+159.0%
share 5.8%
54
+101.9%
share 4.4%
53
share 5.5%
51
share 4.4%
20
share 2.0%
27
share 1.7%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Operative Builders (SIC 1531)
Listed as
DFH (NYSE)
Fiscal year ends
December 31
Incorporated in
TX
Headquarters
Jacksonville, FL
SEC filer status
Accelerated filer
SEC CIK
1825088

Other Operative Builders companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.